Purdue Pharma L.P. v. Intellipharmaceutics International Inc.
1:20-cv-00515
Overview
Parties
Defendant
Intellipharmaceutics Ltd. Operating Company
Represented By
0 Attorneys ListedIntellipharmaceutics Corporation NPE (Individual / Inventor)
Represented By
0 Attorneys ListedIntellipharmaceutics International Inc. Operating Company
Represented By
0 Attorneys ListedPlaintiff
Grunenthal GMBH NPE (Individual / Inventor)
Represented By
3 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Rhodes Technologies NPE (Individual / Inventor)
Represented By
3 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
The P.F. Laboratories, Inc. Operating Company
Represented By
3 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Purdue Pharmaceuticals LP NPE (University / Research)
Represented By
3 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Purdue Pharma L.P. NPE (University / Research)
Represented By
3 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 21 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | US 10,407,434 B2 Asserted | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 10,689,389 B2 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 10,696,684 B2 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 11,384,091 B2 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 11,236,098 B2 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 2023015954 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 12,060,361 B2 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 55,749,204 P | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 60,153,404 P | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 62,007,204 P | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 64,862,505 P | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 65,177,805 P | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 7,129,248 B2 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 2006017302 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 7,683,072 B2 | US Continuation / Sibling | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Patents Involved
There are 2 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US10407434
Process for preparing oxycodone compositions
|
Filed: 2019-01-30
Issued: 2019-09-10
|
Active (12.2 yrs remaining)
Expires: 2039-01-30
|
|
|
US10369109
Abuse-proofed dosage form
|
Filed: 2018-07-11
Issued: 2019-08-06
|
Active (11.6 yrs remaining)
Expires: 2038-07-11
|
Patent Enforceability & Injunction Risk Assessment
Active Threat — Patent is within enforceable statutory term. Patentee retains legal standing to seek permanent injunctive relief and exclusion orders.
Standard Statutory Term — No obviousness-type double patenting truncation noted.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. 4th Year Maintenance Fee Paid (8th Year Window Upcoming).